Literature DB >> 24688939

Effects of royal jelly supplementation on body weight and dietary intake in type 2 diabetic females.

Samira Pourmoradian1, Reza Mahdavi2, Majid Mobasseri3, Elnaz Faramarzi1, Mehrnoosh Mobasseri4.   

Abstract

BACKGROUND: The objective of the current study was to assess the effects of royal jelly supple-mentation on body weight, total daily energy and macronutrients intakes in type2 diabetic fe-males.
METHODS: In this randomized clinical trial, fifty female volunteers with type2 diabetes were as-signed into the supplemented (n=25) and placebo (n=25) groups, given a daily dose of 1000 mg royal jelly soft gel or placebo, for 8 weeks, respectively. Before and after the intervention, body weight and height of subjects were measured and body mass index was calculated. Dietary intake of patients was assessed using 24-hour food recall questionnaire for three non consecutive days (including 1 weekend day) and analyzed with Nutritionist IV software. The normally distributed data were compared using paired and independent t-tests, where appropriate.
RESULTS: Royal jelly supplementation significantly (P<0.01) decreased the mean body weight (72.45±4.42 vs. 71.00±6.44 kg) while it increased insignificantly in placebo group (73.02±6.44 vs 73.52±6.80 kg). Royal jelly supplementation resulted in significant decrease of mean daily total energy (P<0.01) and carbohydrate (P<0.01) intakes, while in placebo group the mean daily total energy and fat intakes were increased significantly (P<0.05).
CONCLUSION: Supplementation with royal jelly may be beneficial in weight management of di-abetic patients.

Entities:  

Keywords:  Royal jelly; Type 2 diabetes; Weight management

Year:  2012        PMID: 24688939      PMCID: PMC3963646          DOI: 10.5681/hpp.2012.028

Source DB:  PubMed          Journal:  Health Promot Perspect        ISSN: 2228-6497


  13 in total

1.  Activity of 10-hydroxydecenoic acid from royal jelly against experimental leukaemia and ascitic tumours.

Authors:  G F TOWNSEND; J F MORGAN; B HAZLETT
Journal:  Nature       Date:  1959-05-02       Impact factor: 49.962

Review 2.  Dietary patterns and prevention of type 2 diabetes: from research to clinical practice; a systematic review.

Authors:  Christina-Maria Kastorini; Demosthenes B Panagiotakos
Journal:  Curr Diabetes Rev       Date:  2009-11

3.  Specific hydroxy fatty acids in royal jelly activate TRPA1.

Authors:  Yuko Terada; Masataka Narukawa; Tatsuo Watanabe
Journal:  J Agric Food Chem       Date:  2011-02-24       Impact factor: 5.279

4.  Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats.

Authors:  A Fujii; S Kobayashi; N Kuboyama; Y Furukawa; Y Kaneko; S Ishihama; H Yamamoto; T Tamura
Journal:  Jpn J Pharmacol       Date:  1990-07

Review 5.  Diet and risk of Type II diabetes: the role of types of fat and carbohydrate.

Authors:  F B Hu; R M van Dam; S Liu
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

6.  [Comparative study of anabolizing activity of apilac and methandrostenolone on a model of isolated overload of the rat skeletal muscle].

Authors:  D M Gadzhieva; V V Paniushkin; R D Seĭfulla; Z G Ordzhonikidze
Journal:  Eksp Klin Farmakol       Date:  2002 Jan-Feb

7.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

8.  Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats.

Authors:  Katsu-hiko Tokunaga; Chie Yoshida; Kazu-michi Suzuki; Hiroe Maruyama; Yoshihiro Futamura; Yoko Araki; Satoshi Mishima
Journal:  Biol Pharm Bull       Date:  2004-02       Impact factor: 2.233

9.  Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

Authors:  John M Miles; Lawrence Leiter; Priscilla Hollander; Thomas Wadden; James W Anderson; Michael Doyle; John Foreyt; Louis Aronne; Samuel Klein
Journal:  Diabetes Care       Date:  2002-07       Impact factor: 19.112

10.  Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages.

Authors:  Keizo Kohno; Iwao Okamoto; Osamu Sano; Norie Arai; Kanso Iwaki; Masao Ikeda; Masashi Kurimoto
Journal:  Biosci Biotechnol Biochem       Date:  2004-01       Impact factor: 2.043

View more
  7 in total

1.  Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial.

Authors:  Parvin Dehghan; Bahram Pourghassem Gargari; Mohammad Asgharijafarabadi
Journal:  Health Promot Perspect       Date:  2013-06-30

2.  Royal jelly improves hyperglycemia in obese/diabetic KK-Ay mice.

Authors:  Mei Yoshida; Kaori Hayashi; Risa Watadani; Yoshiyasu Okano; Keiya Tanimura; Jun Kotoh; Daiki Sasaki; Kozo Matsumoto; Akihiko Maeda
Journal:  J Vet Med Sci       Date:  2016-11-26       Impact factor: 1.267

3.  10-Hydroxy-2-decenoic acid, a natural product, improves hyperglycemia and insulin resistance in obese/diabetic KK-Ay mice, but does not prevent obesity.

Authors:  Risa Watadani; Jun Kotoh; Daiki Sasaki; Azusa Someya; Kozo Matsumoto; Akihiko Maeda
Journal:  J Vet Med Sci       Date:  2017-07-22       Impact factor: 1.267

4.  Effects of Royal Jelly Administration on Lipid Profile, Satiety, Inflammation, and Antioxidant Capacity in Asymptomatic Overweight Adults.

Authors:  Ana Petelin; Saša Kenig; Rok Kopinč; Matjaž Deželak; Maša Černelič Bizjak; Zala Jenko Pražnikar
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-13       Impact factor: 2.629

5.  Adaptogenic potential of royal jelly in liver of rats exposed to chronic stress.

Authors:  Douglas Carvalho Caixeta; Renata Roland Teixeira; Leonardo Gomes Peixoto; Helen Lara Machado; Nathalia Belele Baptista; Adriele Vieira de Souza; Danielle Diniz Vilela; Celso Rodrigues Franci; Foued Salmen Espindola
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

6.  Royal Jelly Reduces Cholesterol Levels, Ameliorates Aβ Pathology and Enhances Neuronal Metabolic Activities in a Rabbit Model of Alzheimer's Disease.

Authors:  Yongming Pan; Jianqin Xu; Cheng Chen; Fangming Chen; Ping Jin; Keyan Zhu; Chenyue W Hu; Mengmeng You; Minli Chen; Fuliang Hu
Journal:  Front Aging Neurosci       Date:  2018-03-05       Impact factor: 5.750

7.  Efficacy of a Novel Herbal Formulation (F2) on the Management of Obesity: In Vitro and In Vivo Study.

Authors:  Prakash Raj Pandeya; Ramakanta Lamichhane; Kyung-Hee Lee; Gopal Lamichhane; Se-Gun Kim; Hyun-Ju Jung
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-08       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.